RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Castle Biosciences Stock

Castle Biosciences Employees 2024

Castle Biosciences Employees

133

Ticker

CSTL

ISIN

US14843C1053

WKN

A2PNH3

In 2024, Castle Biosciences employed 133 people, a 0% change from the 133 number of employees in the previous year.

Castle Biosciences Aktienanalyse

What does Castle Biosciences do?

Castle Biosciences Inc is an American company that was founded in 2007. The company's goal is to develop and distribute innovative diagnostic tests for various types of cancer. Castle Biosciences is headquartered in Friendswood, Texas, and has numerous branches throughout North America. The company currently has around 200 employees and a strong management team. The business model of Castle Biosciences is based on the development and marketing of personalized medical tests that can help improve the diagnosis and treatment of cancer patients. Castle Biosciences primarily offers its tests through doctors and medical facilities. The company specializes in the development of prognostic and predictive tests that can provide doctors with important information to create personalized treatment plans for their patients. Castle Biosciences has several divisions specializing in different types of cancer. One of the most important divisions is in the field of dermatology, developing and distributing tests for the diagnosis and prognosis of melanoma and other skin cancer types. Castle Biosciences also offers personalized tests for cancer of the eyes, stomach, and lung. Another important product of Castle Biosciences is the DecisionDx-Melanoma test. The test is a molecular diagnostic procedure that predicts the likelihood of melanoma recurrence. The test utilizes proprietary gene expression analysis to assess the risk of melanoma recurrence within five years after tumor removal. The results of the test can help minimize the risk of relapse and improve the patients' quality of life. Castle Biosciences has also developed the DecisionDx-UM test, a diagnostic test for uveal melanoma, a rare cancer affecting the eyes. The DecisionDx-UM test uses RNA expression to predict the individual metastatic risk of the cancer and support optimal medical management. The company has also specialized in the development of tests for gastric cancer. The CastleTest™ analyzes the transcription activity of 11 genes to determine the risk of tumor spread from the primary gastric location. Castle Biosciences has made significant progress in recent years and continues to expand through the introduction of new products and services in the market. The company emphasizes a certification program and continuous training of doctors and pathologists to support test performance. Additionally, Castle Biosciences has brought together additional knowledge and expertise through partnerships with other companies and institutions to develop innovative solutions for a wider range of cancer types. Overall, Castle Biosciences is a company specializing in innovative solutions for the diagnosis and prognosis of cancer. The personalized tests from Castle Biosciences have the potential to improve the quality of life for cancer patients by providing additional information for individual treatment plans. With its dedicated workforce and successful products, Castle Biosciences will continue to play an important role in the fight against cancer. Castle Biosciences ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Employees Details

Examining Castle Biosciences's Employee Base

Castle Biosciences's employees are a pivotal aspect of its operations, driving innovation, productivity, and growth. The size and composition of the workforce offer insights into the company's scale, diversity, and investment in human capital. Analyzing employee trends and data is essential for understanding Castle Biosciences's operational capacity and future potential.

Year-to-Year Comparison

Assessing Castle Biosciences's employee numbers year-over-year helps in identifying growth patterns, expansions, or contractions. An increasing employee count can indicate scaling operations and investment in talent, while a decrease may signal efficiency improvements, automation, or business challenges.

Impact on Investments

Castle Biosciences's employee data impacts investment decisions by shedding light on the company’s operational efficiency, innovation capability, and sustainability. Investors assess workforce data to gauge the firm's potential to execute strategies, innovate, and adapt to market changes effectively.

Interpreting Employee Trends

Fluctuations in Castle Biosciences’s employee numbers indicate changes in business strategy, operational demands, and market dynamics. Investors and analysts scrutinize these trends to evaluate the company’s strategic positioning, adaptability, and potential for sustainable growth.

Frequently Asked Questions about Castle Biosciences stock

How many employees does Castle Biosciences have this year?

Castle Biosciences has 133 undefined employees this year.

How many employees did Castle Biosciences have compared to the previous year?

Compared to the previous year, Castle Biosciences had 0% more employees.

What impact did the number of employees have on the company Castle Biosciences?

The number of employees has a direct impact on the efficiency and productivity of Castle Biosciences. A higher number of employees can indicate that the company is growing and has more resources to achieve its goals, while a lower number of employees may suggest that the company is saving costs or facing difficulties in recruiting new employees.

What impact did the number of employees have on investors of Castle Biosciences?

The number of employees can also have an impact on investors of Castle Biosciences, as it can be an indicator of the company's growth and financial health. A higher number of employees can promise investors, while a lower number of employees may raise concerns.

How does an increase in equity capital of Castle Biosciences affect the company?

An increase in equity of Castle Biosciences can improve the financial strength of the company and increase its ability to make future investments and fulfill obligations.

How does a reduction in Castle Biosciences's equity affect the company?

A reduction in equity of Castle Biosciences can impair its financial stability and decrease its ability to fulfill future investments and obligations.

What are some factors that influence the equity of Castle Biosciences?

Some factors that can influence the equity of Castle Biosciences include, among others, revenue development, profit and loss statement, dividend payments, and investments.

Why is the equity of Castle Biosciences so important for investors?

The equity of Castle Biosciences is important for investors as it is an indicator of the company's financial stability and provides investors with information on the amount of financial backing the company has in terms of obligations and future investments.

How does the number of employees at Castle Biosciences influence the company?

The number of employees at Castle Biosciences can directly impact the growth and performance of the company. A higher number of employees can lead to increased capacity and productivity, while a lower number of employees may result in reduced efficiency and limitations.

How has the number of employees at Castle Biosciences evolved in recent years?

In recent years, the number of employees at Castle Biosciences has changed by 0.

How many employees does Castle Biosciences currently have?

Castle Biosciences currently has 133 undefined employees.

Why is the number of employees important for investors of Castle Biosciences?

The number of employees is important for investors of Castle Biosciences as it is an indicator of the growth potential and performance of the company. It also provides information on how the company is able to manage and recruit its workforce.

What strategic measures can Castle Biosciences take to change the number of employees?

To change the number of employees, Castle Biosciences can take various measures such as adjusting compensation packages, improving working conditions, conducting recruitment campaigns, and promoting a positive corporate culture. It is important for the company to conduct a thorough assessment of its situation to determine the best strategic actions to change its number of employees.

How much dividend does Castle Biosciences pay?

Over the past 12 months, Castle Biosciences paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Castle Biosciences is expected to pay a dividend of 0 USD.

What is the dividend yield of Castle Biosciences?

The current dividend yield of Castle Biosciences is .

When does Castle Biosciences pay dividends?

Castle Biosciences pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Castle Biosciences?

Castle Biosciences paid dividends every year for the past 0 years.

What is the dividend of Castle Biosciences?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Castle Biosciences located?

Castle Biosciences is assigned to the 'Health' sector.

Wann musste ich die Aktien von Castle Biosciences kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Castle Biosciences from 9/13/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 9/13/2024.

When did Castle Biosciences pay the last dividend?

The last dividend was paid out on 9/13/2024.

What was the dividend of Castle Biosciences in the year 2023?

In the year 2023, Castle Biosciences distributed 0 USD as dividends.

In which currency does Castle Biosciences pay out the dividend?

The dividends of Castle Biosciences are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Castle Biosciences

Our stock analysis for Castle Biosciences Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Castle Biosciences Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.